Services

Four ways to move a health project forward

Each engagement is scoped to the decision you need to make. Start with one service or combine them across the life of a project.

Healthcare investment and feasibility

Feasibility studies, financial strategies and economic models that show whether a health project can be built, run and financed.

Typically for

  • Healthcare investors and development finance
  • Ministries planning new facilities
  • Hospital groups and operators
  • Founders of health manufacturing projects

The problem

A hospital, manufacturing plant or programme may be clearly needed and still not be ready for a financing decision. Ministries, lenders and investors each need different questions answered from the same numbers.

What you might receive

  • Feasibility study and business case
  • Financial strategy and funding options
  • Health economic and financial model with scenario testing
  • Demand, cost and revenue assumptions, documented and stress-tested
  • Investment and risk briefing for decision-makers

How we work

We start from the service the project must deliver, then model demand, workforce, costs and revenue honestly. Assumptions are made explicit so that each stakeholder can test them.

Related experience

Share a short description of the project and the decision you need to make.

Ask about this service

Health systems and public-private partnerships

Partnership and financing structures that bring capital into health systems while keeping quality, access and accountability in public hands.

Typically for

  • Governments and public-health institutions
  • Development organisations
  • Private operators entering public partnerships

The problem

Public budgets alone rarely cover new infrastructure or high-cost care. Partnerships with the private sector can help, but they fail when risks, payment mechanisms and responsibilities are unclear.

What you might receive

  • PPP readiness and options assessment
  • Risk allocation and payment-mechanism analysis
  • Quality and access safeguards for partnership agreements
  • Regional and pooled financing models for specialised care
  • Health financing and efficiency reviews

How we work

We test the institutional conditions around a partnership as carefully as the project itself: who carries demand risk, how the public partner keeps control of quality, and what happens when the contract ends.

Related experience

Tell us about the service gap and the partners involved.

Ask about this service

Regulatory strategy and market access

Regulatory pathways, compliance-by-design programmes and market-access strategies for pharmaceutical, biotech, MedTech and AI products.

Typically for

  • MedTech and AI medical-device companies
  • Pharmaceutical and biotechnology companies
  • Investors assessing regulated health assets

The problem

Innovative products face demanding regulators in the US and Europe and varied requirements across the GCC and Africa. Compliance added late slows everything down.

What you might receive

  • Regulatory pathway assessment (FDA, EMA, EU MDR, SaMD)
  • Compliance-by-design and governance programme
  • Risk, ethics and documentation framework
  • Pricing and market-access assessment for MENA markets
  • Regulatory due diligence for investors

How we work

We help teams classify early, plan one evidence base for several regulators where possible, and treat data, cybersecurity and documentation as design inputs.

Related experience

Describe the product, its stage and your target markets.

Ask about this service

Executive advisory and capability building

Senior advice for leadership teams and practical training in health economics, financing, compliance and market access.

Typically for

  • Boards and executive teams
  • Universities and professional bodies
  • Pharma, biotech and MedTech teams
  • Conference organisers

The problem

Leaders are asked to make investment and policy decisions that depend on economic evidence, regulation and partnerships, often without specialists in the room.

What you might receive

  • Executive briefings and strategic advisory
  • Training in health economics, financing and market access
  • Workshops on compliance and AI medical-device regulation
  • Keynotes, panels and moderation

How we work

Sessions are built around the decisions participants actually face, with practical tools they can apply after the session.

Share the audience, format and timing you have in mind.

Ask about this service

How an engagement runs

The same sequence applies whether we join at the idea stage or before a financing decision.

  1. Define the need

    Who will be served, with what model of care, and at what scale. The service drives the design, not the building.

  2. Test feasibility

    Demand, workforce, capital and running costs modelled honestly, with assumptions every stakeholder can challenge.

  3. Structure the partnership

    Who carries which risk, how payment works, and how quality and access are protected over the life of the contract.

  4. Build in compliance

    Regulatory pathway, governance and documentation designed in from the start, for every market you intend to enter.

  5. Prepare the decision

    A clear, documented case that ministries, boards, financiers and regulators can assess on its merits.

We prepare projects for financing and regulatory decisions. Funding, approvals and outcomes remain the decision of the relevant institutions.

Have a health project that needs to be ready for a decision?

Tell us what you are trying to build, finance or bring to market. Every inquiry is read personally by Dr. Allama Elmehdi.

Start a conversation Invite Dr. Allama to speak